Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.23 (
beta-galactosidase
)
14,648
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Skin and conjunctival biopsy specimens from fourteen patients with neuronal storage diseases were investigated using an electron microscope. The diseases were Tay-Sachs disease, ceroid-lipofuscinosis (Jansky-Bielschowsky type), Niemann-Pick disease (type B), highly suspected
adrenoleukodystrophy
, I-cell disease, mucolipidosis of the
beta-galactosidase
deficient type, Hurler disease, Hunter disease and Morquio disease. This examination provided valuable diagnostic information on some neuronal storage diseases but not on Morquio disease or highly suspected
adrenoleukodystrophy
. False negative results may sometimes occur using this examination method. However, this examination suggests the usefulness of skin and conjunctival biopsy specimens as a diagnostic tool in some neuronal storage diseases.
...
PMID:Electron microscopic examination of skin and conjunctival biopsy specimens in neuronal storage diseases. 23 94
Clinical, neurophysiological and biochemical studies were performed in patients with various forms of
adrenoleukodystrophy (ALD)
and their family members. The patients showed an abnormality in saturated very long chain fatty acids and in the somatosensory and brain stem auditory or visual evoked potentials. Female presumptive carriers without abnormal neurological manifestations also showed abnormality in the somatosensory or brain stem auditory evoked potentials and in saturated very long chain fatty acids. One
ALD
patient and his mother, a female carrier, had the decreased
beta-galactosidase
activity. The increase in saturated very long chain fatty acids was found, not only in sphingomyelin, but also in phosphatidylcholine and phosphatidylserine. Our results suggest that a generalized abnormal metabolism of VLFA and an abnormality in the central nervous system exist in our patients and female carriers.
...
PMID:Adrenoleukodystrophy and variants. Clinical, neurophysiological and biochemical studies in patients and family members. 308 89
A patient with
adrenoleukodystrophy
and his mother, a carrier, showed an elevated ratio of very long-chain fatty acids to long-chain fatty acids and decreased
beta-galactosidase
activity. Other lysosomal enzyme activities were normal except for the borderline level of arylsulfatase-A activity. However, the father and other patients with variant forms of
adrenoleukodystrophy
showed normal
beta-galactosidase
and other lysosomal enzyme activities.
...
PMID:Adrenoleukodystrophy and beta-galactosidase deficiency: patient and carrier. 309 99